» Articles » PMID: 29228625

Long Noncoding RNA Promoted Apoptosis and Increased Cisplatin Chemosensitivity Via Regulating the HnRNP-U-GADD45A Axis in Lung Squamous Cell Carcinoma

Overview
Journal Oncotarget
Specialty Oncology
Date 2017 Dec 13
PMID 29228625
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Chemotherapeutic insensitivity remains one of the major obstacles in clinical treatment of lung squamous cell carcinoma (LSCC). Recently, increasing evidence has suggested that long non-coding RNAs (lncRNAs) promote tumorigenesis in many cancer types. However, the potential biological roles and regulatory mechanisms of lncRNAs in response to cisplatin treatment are poorly understood. Here, we found that lncRNA (surfactant associated 1, pseudogene), highly expressed in lung, was down-regulated in LSCC tissues and could be induced upon cisplatin treatment in LSCC cells. Elevated induced apoptosis and enhanced the sensitivity to cisplatin of LSCC cells. We further identified that hnRNP-U (heterogeneous nuclear ribonucleoprotein U) was down-regulated in LSCCs and positively correlated with patients' poor prognosis as well as SFTA1P. Mechanistic studies revealed that could up-regulate hnRNP-U expression. In addition, we identified that hnRNP-U enhanced cisplatin-induced apoptosis through up-regulation of GADD45A, high expression of which was correlated with good prognosis in LSCC patients. Our findings demonstrated that might serve as a useful biomarker for LSCC diagnosis and a predictor for cisplatin chemotherapy response in patients with LSCC.

Citing Articles

Biological functions and clinic significance of SAF‑A (Review).

Zhang D, Li L, Li M, Cao X Biomed Rep. 2024; 20(6):88.

PMID: 38665420 PMC: 11040223. DOI: 10.3892/br.2024.1776.


A Proximity biotinylation assay with a host protein bait reveals multiple factors modulating enterovirus replication.

Moghimi S, Viktorova E, Gabaglio S, Zimina A, Budnik B, Wynn B PLoS Pathog. 2022; 18(10):e1010906.

PMID: 36306280 PMC: 9645661. DOI: 10.1371/journal.ppat.1010906.


C10orf55, CASC2, and SFTA1P lncRNAs Are Potential Biomarkers to Assess Radiation Therapy Response in Head and Neck Cancers.

Paszkowska A, Kolenda T, Guglas K, Kozlowska-Maslon J, Podralska M, Teresiak A J Pers Med. 2022; 12(10).

PMID: 36294833 PMC: 9605465. DOI: 10.3390/jpm12101696.


High expression of RUVBL1 and HNRNPU is associated with poor overall survival in stage I and II non-small cell lung cancer patients.

Durslewicz J, Jozwicki J, Klimaszewska-Wisniewska A, Zielinska A, Antosik P, Grzanka D Discov Oncol. 2022; 13(1):106.

PMID: 36242708 PMC: 9569266. DOI: 10.1007/s12672-022-00568-0.


Targeting HNRNPU to overcome cisplatin resistance in bladder cancer.

Shi Z, Hao L, Han X, Wu Z, Pang K, Dong Y Mol Cancer. 2022; 21(1):37.

PMID: 35130920 PMC: 8819945. DOI: 10.1186/s12943-022-01517-9.


References
1.
Xiao R, Tang P, Yang B, Huang J, Zhou Y, Shao C . Nuclear matrix factor hnRNP U/SAF-A exerts a global control of alternative splicing by regulating U2 snRNP maturation. Mol Cell. 2012; 45(5):656-68. PMC: 3299905. DOI: 10.1016/j.molcel.2012.01.009. View

2.
Schiller J, Harrington D, Belani C, Langer C, Sandler A, Krook J . Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med. 2002; 346(2):92-8. DOI: 10.1056/NEJMoa011954. View

3.
Kun-Peng Z, Xiao-Long M, Chun-Lin Z . LncRNA FENDRR sensitizes doxorubicin-resistance of osteosarcoma cells through down-regulating ABCB1 and ABCC1. Oncotarget. 2017; 8(42):71881-71893. PMC: 5641097. DOI: 10.18632/oncotarget.17985. View

4.
Perkel J . Visiting "noncodarnia". Biotechniques. 2013; 54(6):301, 303-4. DOI: 10.2144/000114037. View

5.
Wang Y, Qian C, Li X, Zhang Y, He H, Wang J . Genome-scale long noncoding RNA expression pattern in squamous cell lung cancer. Sci Rep. 2015; 5:11671. PMC: 4498179. DOI: 10.1038/srep11671. View